前往化源商城

Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease 2015-09-01

Intracellular Na+ Concentration ([Na+]i) Is Elevated in Diabetic Hearts Due to Enhanced Na+-Glucose Cotransport.

Rebekah Lambert, Sarah Srodulski, Xiaoli Peng, Kenneth B Margulies, Florin Despa, Sanda Despa

文献索引:J. Am. Heart Assoc. 4 , e002183, (2015)

全文:HTML全文

摘要

Intracellular Na(+) concentration ([Na(+)]i) regulates Ca(2+) cycling, contractility, metabolism, and electrical stability of the heart. [Na(+)]i is elevated in heart failure, leading to arrhythmias and oxidative stress. We hypothesized that myocyte [Na(+)]i is also increased in type 2 diabetes (T2D) due to enhanced activity of the Na(+)-glucose cotransporter.To test this hypothesis, we used myocardial tissue from humans with T2D and a rat model of late-onset T2D (HIP rat). Western blot analysis showed increased Na(+)-glucose cotransporter expression in failing hearts from T2D patients compared with nondiabetic persons (by 73±13%) and in HIP rat hearts versus wild-type (WT) littermates (by 61±8%). [Na(+)]i was elevated in HIP rat myocytes both at rest (14.7±0.9 versus 11.4±0.7 mmol/L in WT) and during electrical stimulation (17.3±0.8 versus 15.0±0.7 mmol/L); however, the Na(+)/K(+)-pump function was similar in HIP and WT cells, suggesting that higher [Na(+)]i is due to enhanced Na(+) entry in diabetic hearts. Indeed, Na(+) influx was significantly larger in myocytes from HIP versus WT rats (1.77±0.11 versus 1.29±0.06 mmol/L per minute). Na(+)-glucose cotransporter inhibition with phlorizin or glucose-free solution greatly reduced Na(+) influx in HIP myocytes (to 1.20±0.16 mmol/L per minute), whereas it had no effect in WT cells. Phlorizin also significantly decreased glucose uptake in HIP myocytes (by 33±9%) but not in WT, indicating an increased reliance on the Na(+)-glucose cotransporter for glucose uptake in T2D hearts.Myocyte Na(+)-glucose cotransport is enhanced in T2D, which increases Na(+) influx and causes Na(+) overload. Higher [Na(+)]i may contribute to arrhythmogenesis and oxidative stress in diabetic hearts.© 2015 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.

相关化合物

结构式 名称/CAS号 全部文献
氟化钠 结构式 氟化钠
CAS:7681-49-4
氯化钠 结构式 氯化钠
CAS:7647-14-5
十二烷基硫酸钠 结构式 十二烷基硫酸钠
CAS:151-21-3
2-(N-7-硝基-2,1,3-苯并恶二唑-4-氨基)-2-脱氧-D-葡萄糖 结构式 2-(N-7-硝基-2,1,3-苯并恶二唑-4-氨基)-2-脱氧-D-葡萄糖
CAS:186689-07-6
去氧胆酸钠 结构式 去氧胆酸钠
CAS:302-95-4
氯化钠-35cl 结构式 氯化钠-35cl
CAS:20510-55-8
正钒酸钠 结构式 正钒酸钠
CAS:13721-39-6
2-脱氧-D-葡萄糖 结构式 2-脱氧-D-葡萄糖
CAS:154-17-6
乙二胺四乙酸 结构式 乙二胺四乙酸
CAS:60-00-4